Found: 16
Select item for more details and to access through your institution.
Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22057-8
- By:
- Publication type:
- Article
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 477, doi. 10.1007/s10637-020-01010-4
- By:
- Publication type:
- Article
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0114-x
- By:
- Publication type:
- Article
Targeted mutation detection in breast cancer using MammaSeq™.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis.
- Published in:
- Endocrinology, 2021, v. 162, n. 8, p. 1, doi. 10.1210/endocr/bqab094
- By:
- Publication type:
- Article
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 136, n. 1, p. 253, doi. 10.1007/s10549-012-2262-7
- By:
- Publication type:
- Article
The molecular landscape of premenopausal breast cancer.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0618-8
- By:
- Publication type:
- Article
The molecular landscape of premenopausal breast cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Who's driving anyway? Herculean efforts to identify the drivers of breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0231999
- By:
- Publication type:
- Article
Novel Modeling of Combinatorial miRNA Targeting Identifies SNP with Potential Role in Bone Density.
- Published in:
- PLoS Computational Biology, 2012, v. 8, n. 12, p. 1, doi. 10.1371/journal.pcbi.1002830
- By:
- Publication type:
- Article
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First‐Line Mutant Epidermal Growth Factor Receptor Non‐Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 349, doi. 10.1002/cpt.3113
- By:
- Publication type:
- Article
Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information.
- Published in:
- BMC Genomics, 2012, v. 13, n. Suppl 1, p. 1, doi. 10.1186/1471-2164-13-S1-S1
- By:
- Publication type:
- Article
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0408-2
- By:
- Publication type:
- Article